NDC11 68462095210
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 68462-0952-10 | 68462-0952 |
| 68462-952-10 | 68462-952 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OLANZAPINE | OLANZAPINE | GLENMARK PHARMACEUTICALS INC., USA | 2e709eaf-4116-4ee3-8dff-ace36181d115 | 2026-04-08 | Boxed warning, Warnings, Adverse reactions | 68462-952-10 68462-952 68462095210 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.